pre-miRNA Information
pre-miRNA hsa-mir-3135a   
Genomic Coordinates chr3: 20137565 - 20137641
Description Homo sapiens miR-3135a stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3135a
Sequence 10| UGCCUAGGCUGAGACUGCAGUG |31
Evidence Experimental
Experiments Illumina
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 19 3 + 20137592 26449202, 27587585 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs985884355 3 dbSNP
rs1202916855 20 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol KLF10   
Synonyms EGR-alpha, EGRA, TIEG, TIEG1
Description Kruppel like factor 10
Transcript NM_001032282   
Other Transcripts NM_005655   
Expression
Putative miRNA Targets on KLF10
3'UTR of KLF10
(miRNA target sites are highlighted)
>KLF10|NM_001032282|3'UTR
   1 CAGACCGGAAAGTGAAGAGTCAGAACTAACTTTGGTCTCAGCGGGAGCCAGTGGTGATGTAAAAATGCTTCCACTGCAAG
  81 TCTGTGGCCCCACAACGTGGGCTTAAAGCAGAAGCCCCACAGCCTGGCACGAAGGCCCCGCCTGGGTTAGGTGACTAAAA
 161 GGGCTTCGGCCACAGGCAGGTCACAGAAAGGCAGGTTTCATTTCTTATCACATAAGAGAGATGAGAAAGCTTTTATTCCT
 241 TTGAATATTTTTTGAAGGTTTCAGATGAGGTCAACACAGGTAGCACAGATTTTGAATCTGTGTGCATATTTGTTACTTTA
 321 CTTTTGCTGTTTATACTTGAGACCAACTTTTCAATGTGATTCTTCTAAAGCACTGGTTTCAAGAATATGGAGGCTGGAAG
 401 GAAATAAACATTACGGTACAGACATGGAGATGTAAAATGAGTTTGTATTATTACAAATATTGTCATCTTTTTCTAGAGTT
 481 ATCTTCTTTATTATTCCTAGTCTTTCCAGTCAACATCGTGGATGTAGTGATTAAATATATCTAGAACTATCATTTTTACA
 561 CTATTGTGAATATTTGGAATTGAACGACTGTATATTGCTAAGAGGGCCCAAAGAATTGGAATCCTCCTTAATTTAATTGC
 641 TTTGAAGCATAGCTACAATTTGTTTTTGCATTTTTGTTTTGAAAGTTTAACAAATGACTGTATCTAGGCATTTCATTATG
 721 CTTTGAACTTTAGTTTGCCTGCAGTTTCTTGTGTAGATTTGAAAATTGTATACCAATGTGTTTTCTGTAGACTCTAAGAT
 801 ACACTGCACTTTGTTTAGAAAAAAAACTGAAGATGAAATATATATTGTAAAGAAGGGATATTAAGAATCTTAGATAACTT
 881 CTTGAAAAAGATGGCTTATGTCATCAGTAAAGTACCTTTATGTTATGAGGATATAATGTGTGCTTTATTGAATTAGAAAA
 961 TTAGTGACCATTATTCACAGGTGGACAAATGTTGATGTTGTCCTGTTAATTTATAGGCGTTTTTTGGGGATGTGGAGGTA
1041 GTTGGGTAGAAAAATTATTAGAACATTCACTTTTGTTAACAGTATTTCTCTTTTATTCTGTTATATAGTGGATGATATAC
1121 ACAGTGGCAAAACAAAAGTACATTGCTTAAAATATATAGTGAAAAATGTCACTATATCTTCCCATTTAACATTGTTTTTG
1201 TATATTGGGTGTAGATTTCTGACATCAAAACTTGGACCCTTGGAAAACAAAAGTTTTAATTAAAAAAAATCCTTGTGACT
1281 TACAATTTGCACAATATTTCTTTTGTTGTACTTTATATCTTGTTTACAATAAAGAATTCCCTTTGGTATATGGAAAAAAA
1361 AAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' gugacguCAGAGUCGGAUCCGu 5'
                 | ||   :|||||| 
Target 5' aacaaatGACTGTATCTAGGCa 3'
689 - 710 127.00 -15.11
2
miRNA  3' gugaCGUCAGAGUCGGAUCCGu 5'
              | || | | ||||:||: 
Target 5' gcacGAAGGCCCCGCCTGGGTt 3'
127 - 148 126.00 -16.90
3
miRNA  3' guGACGUCAGAGU-CGGAUCCGu 5'
            || |  | |:|  ||||| | 
Target 5' atCTTCTTTATTATTCCTAGTCt 3'
481 - 503 116.00 -6.50
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
1181757 141 ClinVar
COSN30150449 14 COSMIC
COSN30103496 23 COSMIC
COSN30158948 39 COSMIC
COSN30132230 42 COSMIC
COSN30516222 43 COSMIC
COSN30103063 46 COSMIC
COSN31778708 139 COSMIC
COSN28692661 141 COSMIC
COSN26565442 275 COSMIC
COSN26586988 277 COSMIC
COSN26695644 358 COSMIC
COSN21493019 401 COSMIC
COSN31538760 415 COSMIC
COSN30542455 473 COSMIC
COSN31520218 586 COSMIC
COSN4874262 662 COSMIC
COSN29312227 693 COSMIC
COSN20105759 989 COSMIC
COSN31601095 1261 COSMIC
COSN26565441 1279 COSMIC
rs1050969 630 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs772416391 1 dbSNP
rs1363054120 5 dbSNP
rs746104666 6 dbSNP
rs138885279 7 dbSNP
rs201026583 21 dbSNP
rs370999476 25 dbSNP
rs1379414148 28 dbSNP
rs374468113 34 dbSNP
rs779653709 34 dbSNP
rs1310507515 35 dbSNP
rs1052877831 42 dbSNP
rs1249826688 43 dbSNP
rs577208168 50 dbSNP
rs1362646641 52 dbSNP
rs935710808 56 dbSNP
rs558818891 57 dbSNP
rs1023113371 60 dbSNP
rs534246869 72 dbSNP
rs1013083230 76 dbSNP
rs985276127 83 dbSNP
rs566706590 84 dbSNP
rs1470345987 95 dbSNP
rs147192922 96 dbSNP
rs536470594 97 dbSNP
rs1360016102 107 dbSNP
rs893411821 113 dbSNP
rs879064190 114 dbSNP
rs1434367191 118 dbSNP
rs1174442324 122 dbSNP
rs922583457 128 dbSNP
rs1176471481 130 dbSNP
rs977061728 139 dbSNP
rs1376248296 140 dbSNP
rs3191333 141 dbSNP
rs1354896113 142 dbSNP
rs1014855565 149 dbSNP
rs548124839 158 dbSNP
rs1365701823 161 dbSNP
rs75455872 167 dbSNP
rs944798750 168 dbSNP
rs1192169532 170 dbSNP
rs752557515 171 dbSNP
rs1217329655 178 dbSNP
rs1028242356 190 dbSNP
rs532126425 206 dbSNP
rs1261906250 211 dbSNP
rs1050723086 212 dbSNP
rs1001752009 216 dbSNP
rs1438728726 216 dbSNP
rs1220425115 227 dbSNP
rs571311515 229 dbSNP
rs930503239 245 dbSNP
rs1489230263 253 dbSNP
rs764753005 262 dbSNP
rs1199530980 273 dbSNP
rs906020885 277 dbSNP
rs1211118989 282 dbSNP
rs1476840529 284 dbSNP
rs113295876 296 dbSNP
rs1172719813 305 dbSNP
rs1046007480 312 dbSNP
rs1404522857 320 dbSNP
rs1254015465 325 dbSNP
rs1406935701 335 dbSNP
rs1232187012 336 dbSNP
rs1339931835 337 dbSNP
rs767362094 339 dbSNP
rs891484307 343 dbSNP
rs371471779 346 dbSNP
rs935743387 350 dbSNP
rs1339907267 354 dbSNP
rs1288081757 355 dbSNP
rs1313599208 359 dbSNP
rs1222750773 362 dbSNP
rs940576381 365 dbSNP
rs1487002485 374 dbSNP
rs925685204 381 dbSNP
rs774493439 384 dbSNP
rs927662434 388 dbSNP
rs143622457 392 dbSNP
rs1472390097 393 dbSNP
rs537662986 404 dbSNP
rs1415684233 410 dbSNP
rs373863236 414 dbSNP
rs763139201 415 dbSNP
rs1462782112 432 dbSNP
rs1320323059 434 dbSNP
rs1327532983 438 dbSNP
rs907890572 447 dbSNP
rs983378665 448 dbSNP
rs542758749 451 dbSNP
rs952047284 460 dbSNP
rs1027774542 468 dbSNP
rs1422283214 480 dbSNP
rs1188118378 481 dbSNP
rs1284834592 482 dbSNP
rs1350984039 483 dbSNP
rs184619832 485 dbSNP
rs1284283869 486 dbSNP
rs999128646 487 dbSNP
rs1185328107 489 dbSNP
rs970272735 489 dbSNP
rs1239031316 490 dbSNP
rs1444996158 490 dbSNP
rs1024868943 497 dbSNP
rs967607720 502 dbSNP
rs1379950237 505 dbSNP
rs1014525820 517 dbSNP
rs770078734 518 dbSNP
rs1160383751 523 dbSNP
rs1018977745 524 dbSNP
rs1414465949 538 dbSNP
rs892016927 542 dbSNP
rs1031343706 546 dbSNP
rs12547834 549 dbSNP
rs904179156 551 dbSNP
rs1308904741 559 dbSNP
rs1480807511 560 dbSNP
rs889088929 563 dbSNP
rs1049517936 566 dbSNP
rs1279697464 577 dbSNP
rs932370577 580 dbSNP
rs1216687412 585 dbSNP
rs901019802 586 dbSNP
rs1317288459 592 dbSNP
rs1236070821 609 dbSNP
rs781543183 616 dbSNP
rs1184241638 617 dbSNP
rs1364496870 624 dbSNP
rs191662533 626 dbSNP
rs939945033 629 dbSNP
rs1050969 630 dbSNP
rs1470558816 634 dbSNP
rs1036592647 638 dbSNP
rs1398556170 649 dbSNP
rs983997339 651 dbSNP
rs940637305 656 dbSNP
rs188298949 664 dbSNP
rs1046081298 666 dbSNP
rs920571501 675 dbSNP
rs1230478844 681 dbSNP
rs540246852 682 dbSNP
rs980226648 683 dbSNP
rs947731923 685 dbSNP
rs916208552 693 dbSNP
rs970517253 695 dbSNP
rs1167744867 699 dbSNP
rs1024484280 700 dbSNP
rs1366225313 702 dbSNP
rs926170256 704 dbSNP
rs1186373268 710 dbSNP
rs1419343789 715 dbSNP
rs1239764559 718 dbSNP
rs1271129444 725 dbSNP
rs977972640 731 dbSNP
rs1457163405 733 dbSNP
rs747364732 747 dbSNP
rs375649565 752 dbSNP
rs536609520 755 dbSNP
rs1463874154 756 dbSNP
rs1031961822 762 dbSNP
rs1389572271 770 dbSNP
rs1384658189 776 dbSNP
rs1304490681 780 dbSNP
rs1000435798 796 dbSNP
rs1345588827 796 dbSNP
rs904207664 800 dbSNP
rs1028378229 801 dbSNP
rs1354313154 804 dbSNP
rs1019217673 805 dbSNP
rs1009117148 812 dbSNP
rs996618457 819 dbSNP
rs1379469923 827 dbSNP
rs1029380634 833 dbSNP
rs1307366487 836 dbSNP
rs900881424 840 dbSNP
rs1260302433 845 dbSNP
rs1430742955 846 dbSNP
rs1194361450 848 dbSNP
rs1368241350 852 dbSNP
rs1456125896 854 dbSNP
rs994959275 857 dbSNP
rs1372222774 862 dbSNP
rs1418584350 865 dbSNP
rs1326052094 868 dbSNP
rs1040770604 869 dbSNP
rs899228977 872 dbSNP
rs1363991518 873 dbSNP
rs1382701291 876 dbSNP
rs148334775 876 dbSNP
rs1338455026 878 dbSNP
rs376319855 884 dbSNP
rs1048319956 887 dbSNP
rs931197123 895 dbSNP
rs1215991434 897 dbSNP
rs1046300326 899 dbSNP
rs947949868 903 dbSNP
rs920617112 904 dbSNP
rs1355139421 906 dbSNP
rs980474906 909 dbSNP
rs1443138959 912 dbSNP
rs1381711643 917 dbSNP
rs1176398689 943 dbSNP
rs1185756591 948 dbSNP
rs1385508222 959 dbSNP
rs1438802090 968 dbSNP
rs916258804 980 dbSNP
rs1346454968 983 dbSNP
rs866010772 993 dbSNP
rs868528418 994 dbSNP
rs3842195 1001 dbSNP
rs397746174 1001 dbSNP
rs1302172591 1002 dbSNP
rs6935 1018 dbSNP
rs917377243 1019 dbSNP
rs992904354 1021 dbSNP
rs1383817958 1023 dbSNP
rs1239680759 1025 dbSNP
rs1289224828 1026 dbSNP
rs1305043889 1028 dbSNP
rs1318776317 1031 dbSNP
rs977804767 1032 dbSNP
rs1255941326 1040 dbSNP
rs1460338694 1045 dbSNP
rs1205967883 1046 dbSNP
rs1457097095 1048 dbSNP
rs184119705 1053 dbSNP
rs753422024 1058 dbSNP
rs375821965 1062 dbSNP
rs967542872 1070 dbSNP
rs956221197 1081 dbSNP
rs569394051 1088 dbSNP
rs987738200 1090 dbSNP
rs979050781 1093 dbSNP
rs1470882543 1094 dbSNP
rs1337216416 1102 dbSNP
rs953597217 1104 dbSNP
rs1446373961 1105 dbSNP
rs1296643976 1106 dbSNP
rs547521715 1109 dbSNP
rs1027993203 1113 dbSNP
rs996956957 1114 dbSNP
rs963527679 1118 dbSNP
rs1322045911 1119 dbSNP
rs1225871539 1120 dbSNP
rs1264191107 1127 dbSNP
rs1317662565 1134 dbSNP
rs1015430319 1138 dbSNP
rs1434939426 1139 dbSNP
rs965008155 1142 dbSNP
rs557016464 1154 dbSNP
rs1331089278 1156 dbSNP
rs1422714350 1157 dbSNP
rs1408021978 1158 dbSNP
rs1003902695 1174 dbSNP
rs1024733460 1177 dbSNP
rs1443124425 1183 dbSNP
rs1400007097 1187 dbSNP
rs1361930353 1196 dbSNP
rs886958906 1200 dbSNP
rs1343689118 1207 dbSNP
rs1407356500 1208 dbSNP
rs1284512578 1211 dbSNP
rs1317805416 1215 dbSNP
rs1048184440 1222 dbSNP
rs115948454 1262 dbSNP
rs772932960 1270 dbSNP
rs775151449 1270 dbSNP
rs1395456534 1274 dbSNP
rs905068075 1277 dbSNP
rs1289007816 1281 dbSNP
rs1044985458 1283 dbSNP
rs1199444010 1289 dbSNP
rs948763222 1294 dbSNP
rs936344577 1314 dbSNP
rs531311734 1315 dbSNP
rs1188057090 1316 dbSNP
rs1419945975 1317 dbSNP
rs1410804952 1333 dbSNP
rs370479100 1339 dbSNP
rs1193852783 1342 dbSNP
rs1363894893 1349 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gugacguCAGAGUCGGAUCcgu 5'
                 | ||   :||||   
Target 5' aacaaauGACUGUAUCUAG--- 3'
8 - 26
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM545216
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / miR-124 transfection
Location of target site ENST00000285407.6 | 3UTR | UUUAACAAAUGACUGUAUCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000285407.6 | 3UTR | AAAGUUUAACAAAUGACUGUAUCUAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
Click to see details
Click to see details
Click to see details
39 hsa-miR-3135a Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT092740 SETD5 SET domain containing 5 2 4
MIRT098840 PCMT1 protein-L-isoaspartate (D-aspartate) O-methyltransferase 2 2
MIRT462095 TMEM214 transmembrane protein 214 2 2
MIRT467617 SLC7A5 solute carrier family 7 member 5 2 2
MIRT471258 PGM2L1 phosphoglucomutase 2 like 1 2 2
MIRT474676 KLF10 Kruppel like factor 10 2 4
MIRT474882 KCTD5 potassium channel tetramerization domain containing 5 2 4
MIRT495898 DESI1 desumoylating isopeptidase 1 2 2
MIRT511377 IKZF3 IKAROS family zinc finger 3 2 2
MIRT534180 SLC8A1 solute carrier family 8 member A1 2 2
MIRT540056 CEP104 centrosomal protein 104 2 2
MIRT540147 GTF2B general transcription factor IIB 2 4
MIRT540184 GSTM4 glutathione S-transferase mu 4 2 2
MIRT540465 ZNF71 zinc finger protein 71 2 2
MIRT540584 ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit 2 4
MIRT542390 WDR12 WD repeat domain 12 2 2
MIRT542407 SYNJ2BP synaptojanin 2 binding protein 2 2
MIRT542657 TAF11 TATA-box binding protein associated factor 11 2 2
MIRT544052 C9orf64 chromosome 9 open reading frame 64 2 2
MIRT551350 AGBL5 ATP/GTP binding protein like 5 2 2
MIRT556685 KLHL28 kelch like family member 28 2 2
MIRT561678 RAD54L2 RAD54 like 2 2 2
MIRT576721 Wars tryptophanyl-tRNA synthetase 2 2
MIRT610461 SYNPO2L synaptopodin 2 like 2 4
MIRT632361 SRRD SRR1 domain containing 2 2
MIRT636713 ARSK arylsulfatase family member K 2 2
MIRT637684 PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D 2 2
MIRT648531 KIAA1143 KIAA1143 2 2
MIRT658732 ELK1 ELK1, ETS transcription factor 2 2
MIRT666554 RNF115 ring finger protein 115 2 2
MIRT667689 KNSTRN kinetochore localized astrin/SPAG5 binding protein 2 2
MIRT668169 GDE1 glycerophosphodiester phosphodiesterase 1 2 2
MIRT668634 DYRK1A dual specificity tyrosine phosphorylation regulated kinase 1A 2 2
MIRT668692 DNAL1 dynein axonemal light chain 1 2 2
MIRT679412 GMCL1 germ cell-less, spermatogenesis associated 1 2 2
MIRT692259 SLC2A5 solute carrier family 2 member 5 2 2
MIRT693281 GINM1 glycoprotein integral membrane 1 2 2
MIRT698158 TNFRSF13C TNF receptor superfamily member 13C 2 2
MIRT705567 ARHGEF18 Rho/Rac guanine nucleotide exchange factor 18 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-31 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray Pancreatic Cancer MiaPACA-2 cells 19407485 2009 up-regulated
miR-31 5-aza-2'-deoxycytidine (5-Aza-CdR) + trichostatin A(TSA) NULL NULL Microarray Pancreatic Cancer MiaPACA-2 cells 19407485 2009 up-regulated
miR-31 Trichostatin A (TSA) NULL 444732 Microarray Pancreatic Cancer MiaPACA-2 cells 19407485 2009 up-regulated
miR-31 5-Fluorouracil approved 3385 Microarray HCT-116 colon cancer cell line 19956872 2010 down-regulated
miR-31 Ginsenoside Rh2 NULL 119307 Microarray NSCLC cell line A549 23152132 2013 down-regulated
miR-31 Doxorubicin approved 31703 Microarray heart 22859947 2012 up-regulated
miR-31 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) NULL 15625 Quantitative real-time PCR thymus 23024791 2012 down-regulated
miR-31 Tamoxifen approved 2733526 Microarray rat liver 17343880 2007 up-regulated
miR-31 Budesonide approved 5281004 Microarray neonatal mice liver 20145010 2010 down-regulated
miR-31 Phenethyl isothiocyanate(PEITC) NULL 16741 Microarray neonatal mice liver 20145010 2010 down-regulated
miR-31 Leptin NULL NULL Quantitative real-time PCR muscles 20800581 2010 up-regulated
miR-31 Cocaine NULL 446220 Next-generation sequencing ventral striatum 21708909 2011 down-regulated
miR-31 Longevinex NULL NULL Quantitative real-time PCR ischemia/reperfusion [I/R] rat model 21203465 2011 down-regulated
miR-31 Longevinex NULL NULL Quantitative real-time PCR normal heart 21203465 2011 up-regulated
miR-31 Resveratrol NULL 445154 Quantitative real-time PCR ischemia/reperfusion [I/R] rat model 21203465 2011 down-regulated
miR-31 Resveratrol NULL 445154 Quantitative real-time PCR normal heart 21203465 2011 up-regulated
miR-31 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 up-regulated
miR-31 Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 up-regulated
miR-31 Calcium sulfate (CaS) NULL 24497 Microarray MG63E osteoblast-like cells 17618507 2008 down-regulated
miR-31 Valproate approved 3121 Quantitative real-time PCR CD4+, CD25- T cells 20427269 2010 down-regulated
miR-31 Enoxacin approved 3229 Quantitative real-time PCR HCT-116 and RKO colon cancer cell lines 21368194 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-31 Tamoxifen 2733525 NSC180973 approved sensitive Low Breast Cancer cell line (MCF-7, T47D)
hsa-mir-31 Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (HepG2, SK-HEP-1)
hsa-mir-31 Cisplatin 5460033 NSC119875 approved sensitive High Lung Adenocarcinoma cell line (A549)
hsa-mir-31 Dabrafenib 44462760 NSC764134 approved sensitive cell line (A375)
hsa-mir-31 Paclitaxel 36314 NSC125973 approved sensitive cell line (BAS)
hsa-mir-31 Doxorubicin 31703 NSC123127 approved sensitive cell line (BAS)
hsa-mir-31 Paclitaxel 36314 NSC125973 approved sensitive cell line (W1)
hsa-mir-31 Cisplatin 5460033 NSC119875 approved sensitive cell line (W1)
hsa-mir-31 Methotrexate 126941 NSC740 approved sensitive cell line (W1)
hsa-mir-31 Topotecan 60699 NSC609699 approved sensitive cell line (W1)
hsa-mir-31 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-mir-31 Androstenedione 6128 NSC9563 resistant cell line (MCF-7)
hsa-mir-31 Androstenedione+Anastrozole resistant cell line (MCF-7)
hsa-mir-31 Cisplatin 5460033 NSC119875 approved resistant cell line (KYSE)
hsa-mir-31 Tamoxifen 2733525 NSC180973 approved sensitive cell line (MCF7)
hsa-miR-3135a Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (COC1)
hsa-mir-3135a Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-3135a Docetaxel+Cisplatin+5-Fluorouracil resistant tissue (hypopharyngeal squamous cell carcinoma)
hsa-miR-3135a Palbociclib 5330286 NSC758247 approved sensitive tissue (breast cancer)
hsa-miR-3135a Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3135a Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)

Error report submission